High-Throughput Architecture for Discovering Combination Cancer Therapeutics

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• Vast amounts of next-generation sequencing and clinical data have transformed cancer research.
• Accessible analysis tools are needed to process large datasets and identify combination therapies.
• Current challenges include efficient data analysis and discovery of synergistic drug combinations.

Purpose of the Study:

• To develop a software architecture for integrating and analyzing large-scale sequencing and clinical data.
• To enable efficient prediction of potential combination drug targets.
• To address the unmet need for tools in translational cancer research.

Main Methods:

• Created a software architecture for integrating diverse datasets (sequencing, clinical).
• Enabled prediction of gene pair targets for combination therapies.
• Integrated graph analytics to identify synergistic pathways.

Main Results:

• Identified potentially synergistic target pairs for 38 approved targets.
• Showcased synergistic prediction markers and targets for melanoma treatment with MAPK/ERK inhibitors.
• Discovered pathways for synergistic targeting to enhance therapeutic efficacy.

Conclusions:

• The developed architecture provides a foundation for discovering effective combination therapeutics.
• Results offer insights into synergistic gene pairs and pathways for cancer treatment.
• The approach facilitates the identification of novel combination drug strategies.